Why the study?
Although sedentary time can be reduced during cardiac rehabilitation in CAD patients, most patients relapse to sedentarism within months.
Does a 3-week remote behavioral change booster intervention reduce sedentary time in patients with coronary artery disease who previously completed cardiac rehabilitation?
Does a 3-week remote behavioral change booster intervention reduce sedentary time in patients with coronary artery disease who previously completed cardiac rehabilitation?
A 3-week remote eHealth booster program effectively reduces sedentary time and increases light physical activity in CAD patients years after completing cardiac rehabilitation.
Supports remote boosters to curb sedentary time in CAD patients post-rehab; extends cardiac rehabilitation benefits long-term.
AIMS: Sedentary time (ST) can be reduced in patients with coronary artery disease (CAD) during cardiac rehabilitation (CR), but most patients relapse to sedentarism within months. We examined the effectiveness of a 3-week remote booster intervention on ST changes in CAD patients. METHODS: CAD patients who previously (2.0 [1.9-2.2] years) completed CR were included in this randomized controlled trial (1:1, stratified for gender). All participants received usual care, whereas booster participants additionally received a 3-week remote behavioral change intervention. The primary outcome was the change in accelerometer-derived ST from baseline to post-intervention and secondary outcomes included changes in sedentary behaviour and physical activity (PA) characteristics. A baseline constrained linear mixed-model on an intention-to-treat basis was used. RESULTS: Participants (19% female, booster: n=21, control: n=21) were 69 [63-75] years old. Greater decreases in ST (-1.3 (95% confidence interval (CI): -2.0; -0.6) versus -0.1 (95% CI: -0.8; 0.6) h/day, p-interaction=0.012) and number of prolonged sedentary bouts (-1.1 (95% CI: -1.6; -0.6) versus 0.2 (95% CI: -0.3; 0.7) bouts/day, p-interaction<0.001) in combination with larger increases in light PA (+1.1 (95% CI: +0.5; +1.8) versus +0.2 (95% CI: -0.4; +0.8) h/day, p-interaction=0.030) were found for the booster versus control group. Changes in moderate-to-vigorous PA (p-interaction=0.13) and step count (p-interaction=0.18) did not differ between groups. CONCLUSION: The remote booster program effectively reduced ST and increased light PA in CAD patients. These findings highlight the potential to change physical (in)activity behaviour of patients beyond completion of traditional CR programs. TRIAL REGISTRATION: NCT06038188 (Clinical Trials.gov).
No takes yet. Share an insight, caveat, or question.
Kroesen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: